Valuation CSL Limited Deutsche Boerse AG

Stocks

Delayed Deutsche Boerse AG Other stock markets 10:10:28 31/07/2026 +04			5-day change	1st Jan Change
17.70 ^EUR	-3.28%		+6.63%	-25.63%

11:37am	Australian shares log best month since February as rate-hike worries ease	RE
07:00am	ASX Midday Sector Update: Materials Stocks Soar, Healthcare Sector Struggles	MT

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	97,314	89,299	89,052	95,184	76,024	41,311	-	-
Change	-	-8.24%	-0.28%	6.89%	-20.13%	-45.66%	-	-
Enterprise Value (EV) ¹	101,307	88,520	99,731	105,710	85,005	49,925	49,177	48,556
Change	-	-12.62%	12.66%	5.99%	-19.59%	-41.27%	-1.5%	-1.26%
P/E	41x	38.6x	40.8x	36.1x	25.4x	-46.2x	28.8x	13.4x
PBR	11.6x	6.13x	5.64x	5.48x	3.93x	2.57x	2.55x	2.34x
PEG	-	-4.91x	-7.25x	1.8x	1.9x	0x	-0x	0x
Capitalization / Revenue	9.44x	8.45x	6.69x	6.43x	4.89x	2.69x	2.65x	2.55x
EV / Revenue	9.83x	8.38x	7.49x	7.14x	5.46x	3.25x	3.16x	3x
EV / EBITDA	27.2x	24.6x	25.6x	22.3x	16.5x	9.6x	9.57x	9.03x
EV / EBIT	32.4x	30.2x	32.5x	27.7x	19x	11.2x	11.2x	10.6x
EV / FCF	41.8x	57.1x	72.6x	55.2x	29.1x	18.1x	16.4x	16.8x
FCF Yield	2.39%	1.75%	1.38%	1.81%	3.44%	5.53%	6.1%	5.97%
Dividend per Share ²	2.22	2.22	2.36	2.64	2.92	2.845	2.916	3.077
Rate of return	1.04%	1.2%	1.28%	1.34%	1.86%	3.3%	3.38%	3.57%
EPS ²	5.21	4.8	4.53	5.45	6.17	-1.867	2.999	6.459
Distribution rate	42.6%	46.3%	52.1%	48.4%	47.3%	-152%	97.2%	47.6%
Net sales ¹	10,310	10,562	13,310	14,800	15,558	15,380	15,583	16,180
EBITDA ¹	3,720	3,596	3,900	4,750	5,151	5,200	5,139	5,379
EBIT ¹	3,130	2,927	3,069	3,812	4,468	4,459	4,410	4,602
Net income ¹	2,375	2,255	2,194	2,642	3,002	-966.7	1,185	3,090
Net Debt ¹	3,993	-778.6	10,679	10,526	8,981	8,614	7,866	7,245
Reference price ²	213.82	185.38	184.61	196.96	157.01	86.26	86.26	86.26
Nbr of stocks (in thousands)	455,126	481,706	482,372	483,253	484,212	478,912	-	-
Announcement Date	17/08/21	16/08/22	14/08/23	12/08/24	18/08/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	16.67x	4.1x	9.59x	0.52%	75.12B
UCB	23.58x	4.83x	14.44x	0.67%	47.63B
SAMSUNG BIOLOGICS CO.,LTD.	37.18x	12.72x	24.2x	-.--%	49.48B
BIOGEN INC.	38.13x	3.45x	12x	-.--%	30.72B
INCYTE CORPORATION	56.6x	3.48x	26.97x	-.--%	24.93B
MODERNA, INC.	-6.68x	9.36x	-5.75x	-.--%	22.98B
INNOVENT BIOLOGICS, INC.	63.54x	6.22x	42.81x	-.--%	19.56B
SWEDISH ORPHAN BIOVITRUM AB	24.79x	5.31x	13.83x	-.--%	17.19B
BRIDGEBIO PHARMA, INC.	-36.92x	17.57x	-48.11x	-.--%	16.06B
Average	24.10x	7.45x	10.00x	0.13%	33.74B
Weighted average by Cap.	25.42x	6.82x	12.57x	0.24%